FDA clears AI-guided magnetic stimulation therapy for PTSD

California-based Wave Neuroscience and Texas A&M received FDA clearance for MeRT, a PTSD therapy that uses EEG and an AI algorithm to personalize transcranial magnetic stimulation. In the trial, symptoms fell 52% and 68% of patients achieved remission.

• MeRT combines EEG readings, an AI algorithm and TMS magnetic stimulation
• PTSD symptoms dropped 52%, with 68% of trial patients in remission
• The technology received FDA Breakthrough Device designation in 2024
• About 13 million people in the US may be eligible for the treatment